Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06946470
ABSTRACT:
A method of treating psychosis in a patient which comprises administering a pharmaceutical composition useful in treating psychosis containing a therapeutically effective amount of 1-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one as an active ingredient.
REFERENCES:
patent: 5158953 (1992-10-01), Chern et al.
patent: 5340814 (1994-08-01), Chern et al.
patent: 5512677 (1996-04-01), Chern et al.
patent: 5932584 (1999-08-01), Chern et al.
Chern Ji-Wang
Ko Feng-Nien
Bacon & Thomas
McKenzie Thomas C.
Medical and Pharmaceutical Industry Technology and Development C
National Science Council
LandOfFree
Method of treating psychosis in a patient does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating psychosis in a patient, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating psychosis in a patient will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3402598